Fastbase, Lambert to Implement Cancer Diagnostic Platform
Proteomic technology developer Fastbase Solutions and imaging solutions developer Lambert Instruments BV have announced a strategic partnership to implement a new cancer diagnostics platform.
The system will be delivered using Lambert Instruments’ FLIM [fluorescence lifetime imaging microscopy] Attachment technology. Fastbase Solutions’ image acquisition and analysis platform is based on fluorescence lifetime imaging technology developed by Lambert Instruments.
”The Lambert Instruments FLIM technology provides us with the tools we need to build our quantitative biomarker platform and accelerate our growth as a young company,” said Banafshé Larijani, chief sales officer of Fastbase.
Lambert Instruments develops advanced imaging solutions for low-light applications. Fastbase Solutions implements new technology for functional proteomic insight.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024